Geographic · D&A
EMEA — D&A
Zimmer Biomet Holdings EMEA — D&A decreased by 1.8% to $16.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $15.60M to $16.50M. Over 4 years (FY 2021 to FY 2025), EMEA — D&A shows relatively stable performance with a -1.9% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
Rolls up toD&A
How to read this metric
An increase may indicate higher capital investment in regional infrastructure, while a decrease could signal aging assets or reduced capital expenditure.
Detailed definition
This metric represents the non-cash expense allocated to the EMEA segment for the systematic reduction in the value of t...
Peer comparison
Standard across medical device peers; typically correlates with the scale of regional manufacturing and distribution footprints.
Metric ID:
zbh_segment_emea_depreciation_and_amortizationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.85M | $17.85M | $17.85M | $16.10M | $16.10M | $16.10M | $16.10M | $16.80M | $16.80M | $16.80M | $16.80M | $16.80M | $16.90M | $16.30M | $15.90M | $15.60M | $16.60M | $17.20M | $16.80M | $16.50M |
| QoQ Change | — | +0.0% | +0.0% | -9.8% | +0.0% | +0.0% | +0.0% | +4.3% | +0.0% | +0.0% | +0.0% | +0.0% | +0.6% | -3.6% | -2.5% | -1.9% | +6.4% | +3.6% | -2.3% | -1.8% |
| YoY Change | — | — | — | — | -9.8% | -9.8% | -9.8% | +4.3% | +4.3% | +4.3% | +4.3% | +0.0% | +0.6% | -3.0% | -5.4% | -7.1% | -1.8% | +5.5% | +5.7% | +5.8% |
Range$15.60M – $17.85M
CAGR-1.6%
Avg YoY Growth-0.7%
Median YoY Growth+0.3%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Zimmer Biomet Holdings's emea — d&a?
- Zimmer Biomet Holdings (ZBH) reported emea — d&a of $16.50M in Q1 2026.
- How has Zimmer Biomet Holdings's emea — d&a changed year-over-year?
- Zimmer Biomet Holdings's emea — d&a increased by 5.8% year-over-year, from $15.60M to $16.50M.
- What is the long-term trend for Zimmer Biomet Holdings's emea — d&a?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's emea — d&a has grown at a -1.9% compound annual growth rate (CAGR), from $71.40M to $66.20M.
- What does emea — d&a mean?
- The annual non-cash cost of wearing out the physical and intangible assets used by the EMEA business segment.